Cargando…

Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma

OBJECTIVE: This study aimed to evaluate the correlation between cervical lymph node metastasis (CLNM) and each of the ultrasound features, immunohistochemical factors, and B-type Raf (BRAF(V600E)) mutation. METHODS: A retrospective analysis was performed on 405 patients with single papillary thyroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Jia, Zhang, Long-hui, Yu, Qing, Li, Chao-lun, Chen, Yue, Wang, Wen-Ping, Ding, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418479/
https://www.ncbi.nlm.nih.gov/pubmed/32843902
http://dx.doi.org/10.1177/1758835920942367
_version_ 1783569699098853376
author Zhan, Jia
Zhang, Long-hui
Yu, Qing
Li, Chao-lun
Chen, Yue
Wang, Wen-Ping
Ding, Hong
author_facet Zhan, Jia
Zhang, Long-hui
Yu, Qing
Li, Chao-lun
Chen, Yue
Wang, Wen-Ping
Ding, Hong
author_sort Zhan, Jia
collection PubMed
description OBJECTIVE: This study aimed to evaluate the correlation between cervical lymph node metastasis (CLNM) and each of the ultrasound features, immunohistochemical factors, and B-type Raf (BRAF(V600E)) mutation. METHODS: A retrospective analysis was performed on 405 patients with single papillary thyroid carcinoma (PTC) nodules, all of whom underwent preoperative sonographic examinations, including gray-scale ultrasound, color Doppler ultrasound, and contrast-enhanced ultrasound (CEUS). All PTC patients were evaluated using 14 clinical and sonographic features, eight immunohistochemical factors, and BRAF(V600E). Multivariate analyses were performed to identify the risk factors for CLNM, and an equation for CLNM was established. The diagnostic value of each modality was compared with a receiver operating characteristic (ROC) curve. RESULTS: Among the 405 PTC nodules removed surgically, CLNM was confirmed in 138 patients, whereas extrathyroidal extension was confirmed in 185 patients. Multivariate analyses indicated significant differences between CLNM and non-CLNM groups in three conventional ultrasound features (p < 0.05), whereas other sonographic features, eight immunohistochemical factors, and BRAF(V600E) did not indicate significant differences. A ROC curve of 0.757 in the equation exhibited a significant difference compared with the solo factors (p < 0.05 for all). Hyper or isoechoic enhancement at peak time on CEUS was associated with CLNM, whereas the presence of the BRAF(V600E) mutation was associated with extrathyroidal extensions although BRAF appeared to be uncorrelated with CLNM in the present study. CONCLUSION: Intensity at peak time, homogeneity, and size are the three most significant features in predicting CLNM in PTC patients, and the presence of the BRAF(V600E) mutation was associated with extrathyroidal extensions when PTCs showed a hyper or isoechoic enhancement at peak time in CEUS.
format Online
Article
Text
id pubmed-7418479
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74184792020-08-24 Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma Zhan, Jia Zhang, Long-hui Yu, Qing Li, Chao-lun Chen, Yue Wang, Wen-Ping Ding, Hong Ther Adv Med Oncol Original Research OBJECTIVE: This study aimed to evaluate the correlation between cervical lymph node metastasis (CLNM) and each of the ultrasound features, immunohistochemical factors, and B-type Raf (BRAF(V600E)) mutation. METHODS: A retrospective analysis was performed on 405 patients with single papillary thyroid carcinoma (PTC) nodules, all of whom underwent preoperative sonographic examinations, including gray-scale ultrasound, color Doppler ultrasound, and contrast-enhanced ultrasound (CEUS). All PTC patients were evaluated using 14 clinical and sonographic features, eight immunohistochemical factors, and BRAF(V600E). Multivariate analyses were performed to identify the risk factors for CLNM, and an equation for CLNM was established. The diagnostic value of each modality was compared with a receiver operating characteristic (ROC) curve. RESULTS: Among the 405 PTC nodules removed surgically, CLNM was confirmed in 138 patients, whereas extrathyroidal extension was confirmed in 185 patients. Multivariate analyses indicated significant differences between CLNM and non-CLNM groups in three conventional ultrasound features (p < 0.05), whereas other sonographic features, eight immunohistochemical factors, and BRAF(V600E) did not indicate significant differences. A ROC curve of 0.757 in the equation exhibited a significant difference compared with the solo factors (p < 0.05 for all). Hyper or isoechoic enhancement at peak time on CEUS was associated with CLNM, whereas the presence of the BRAF(V600E) mutation was associated with extrathyroidal extensions although BRAF appeared to be uncorrelated with CLNM in the present study. CONCLUSION: Intensity at peak time, homogeneity, and size are the three most significant features in predicting CLNM in PTC patients, and the presence of the BRAF(V600E) mutation was associated with extrathyroidal extensions when PTCs showed a hyper or isoechoic enhancement at peak time in CEUS. SAGE Publications 2020-08-06 /pmc/articles/PMC7418479/ /pubmed/32843902 http://dx.doi.org/10.1177/1758835920942367 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Zhan, Jia
Zhang, Long-hui
Yu, Qing
Li, Chao-lun
Chen, Yue
Wang, Wen-Ping
Ding, Hong
Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma
title Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma
title_full Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma
title_fullStr Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma
title_full_unstemmed Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma
title_short Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAF(V600E) and extrathyroidal extension in papillary thyroid carcinoma
title_sort prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of braf(v600e) and extrathyroidal extension in papillary thyroid carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418479/
https://www.ncbi.nlm.nih.gov/pubmed/32843902
http://dx.doi.org/10.1177/1758835920942367
work_keys_str_mv AT zhanjia predictionofcervicallymphnodemetastasiswithcontrastenhancedultrasoundandassociationbetweenpresenceofbrafv600eandextrathyroidalextensioninpapillarythyroidcarcinoma
AT zhanglonghui predictionofcervicallymphnodemetastasiswithcontrastenhancedultrasoundandassociationbetweenpresenceofbrafv600eandextrathyroidalextensioninpapillarythyroidcarcinoma
AT yuqing predictionofcervicallymphnodemetastasiswithcontrastenhancedultrasoundandassociationbetweenpresenceofbrafv600eandextrathyroidalextensioninpapillarythyroidcarcinoma
AT lichaolun predictionofcervicallymphnodemetastasiswithcontrastenhancedultrasoundandassociationbetweenpresenceofbrafv600eandextrathyroidalextensioninpapillarythyroidcarcinoma
AT chenyue predictionofcervicallymphnodemetastasiswithcontrastenhancedultrasoundandassociationbetweenpresenceofbrafv600eandextrathyroidalextensioninpapillarythyroidcarcinoma
AT wangwenping predictionofcervicallymphnodemetastasiswithcontrastenhancedultrasoundandassociationbetweenpresenceofbrafv600eandextrathyroidalextensioninpapillarythyroidcarcinoma
AT dinghong predictionofcervicallymphnodemetastasiswithcontrastenhancedultrasoundandassociationbetweenpresenceofbrafv600eandextrathyroidalextensioninpapillarythyroidcarcinoma